CELLTRION HEALTHCARE HUNGARY KFT

Avtozma is used to treat various inflammatory conditions, including rheumatoid arthritis (RA) in adults, juvenile idiopathic arthritis (JIA s and JIA p) in children and adolescents, giant cell arteritis (GCA) in adults, cytokine release syndrome (CRS), and coronavirus disease 2019 (COVID-19) in patients requiring oxygen or ventilation.

Dosage form: solution for infusion, concentrate

ATC: L04AC07

This medicine is injected into the eye to treat several eye diseases in adults, including age-related neovascular macular degeneration (exudative AMD), macular edema due to retinal vein occlusion (RVO) or diabetes (DME), and myopic choroidal neovascularization (myopic CNV).

Dosage form: solution for injection in pre-filled syringe

ATC: S01LA05

It is prescribed for the treatment of breast cancer (early stage or metastatic) and metastatic gastric cancer, but only in cases where the tumor cells show high levels of a protein called HER2.

Dosage form: powder for concentrate for infusion solution

ATC: L01FD01

Omlyclo is used for the treatment of severe allergic asthma (in adults, adolescents, and children aged 6 years and older), chronic rhinosinusitis with nasal polyps (in adults aged 18 years and older), and chronic spontaneous urticaria (in adults and adolescents aged 12 years and older).

Dosage form: solution for injection in pre-filled syringe

ATC: R03DX05

It is used in adults with advanced cancer to prevent serious complications caused by bone metastases (such as fractures or the need for surgery) and in the treatment of giant cell bone tumor in adults and adolescents whose bones have stopped growing.

Dosage form: solution for injection

ATC: M05BX04

It is used to treat several inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), Crohn's disease (moderate to severe, in adults and children weighing at least 40 kg), and ulcerative colitis (moderate to severe, in adults).

Dosage form: solution for injection in pre-filled syringe

ATC: L04AC05

Remsima is used in adults for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis (Bechterew's disease), psoriasis, Crohn's disease, and ulcerative colitis. It works by reducing inflammation by blocking a protein called TNF alpha.

Dosage form: powder for concentrate for infusion solution

ATC: L04AB02

Steqeyma is an immunosuppressant drug used for the treatment of inflammatory diseases such as plaque psoriasis, psoriatic arthritis, and Crohn's disease (moderate to severe).

Dosage form: solution for injection in pre-filled syringe

ATC: L04AC05

It is used to treat osteoporosis in postmenopausal women and in men at risk of fractures. It is also indicated for bone loss in men caused by reduced testosterone levels (due to surgery or therapy for prostate cancer) and for bone loss due to long-term glucocorticoid use in patients at risk of fracture.

Dosage form: solution for injection in pre-filled syringe

ATC: M05BX04

Truxima is used for the treatment of several conditions, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris.

Dosage form: solution for infusion, concentrate

ATC: L01FA01

It is used for the treatment of several types of cancer in adults, including colorectal cancer (colon or rectum), metastatic breast cancer, non-small cell lung cancer, renal cancer, ovarian cancer (advanced epithelial, fallopian tube, or primary peritoneal), and cervical cancer.

Dosage form: solution for infusion, concentrate

ATC: L01FG01

Yuflyma is a medicine that acts on the immune system and is indicated for the treatment of several inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis, non-infectious uveitis, ankylosing spondylitis, and other forms of arthritis.

Dosage form: solution for injection

ATC: L04AB04